首页 > 市场调查报告书 > 製药

疫苗感染疾病

到 2030 年北美疟疾治疗市场预测 - 区域分析 - 按治疗、给药途径和配销通路

市场调查报告书

商品编码

1510755

到 2030 年北美疟疾治疗市场预测 - 区域分析 - 按治疗、给药途径和配销通路

North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 84 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美疟疾治疗市场估值为6,297万美元，预计2030年将达4.8731亿美元；预计2022年至2030年复合年增长率为29.1%。

疟疾盛行率的增加推动了北美疟疾治疗市场

疟疾是一种急性发烧性疾病，由疟原虫引起，并透过受感染的雌性疟蚊传播。人类体内的五种寄生虫主要引起疟疾，其中两种——恶性疟原虫和间日疟原虫——被认为对人类健康构成最大威胁。此外，恶性疟原虫是最致命的疟疾寄生虫，在非洲大陆传播最广。此外，间日疟原虫是撒哈拉以南非洲以外大多数国家的主要疟疾寄生虫。根据世界卫生组织 (WHO) 最新发布的《2020 年世界疟疾报告》(WMR)，全球报告了 2.41 亿例疟疾病例，而 2019 年记录的病例数为 2.27 亿例。人。其中约三分之二（即 47,000 人）是由于 COVID-19 爆发期间医疗服务中断造成的；其余三分之一的死亡人数，即 22,000 人，反映了世界卫生组织计算疟疾死亡率的方法最近发生的变化（不考虑 COVID-19 的干扰）。因此，疟疾盛行率的上升促进了疟疾治疗市场的成长。

北美疟疾治疗市场概况

根据美国疾病管制与预防中心 (CDC) 的数据，美国每年报告约 2,000 例疟疾病例，其中大部分是来自其他国家的旅客和移民。孕妇和 5 岁以下儿童感染疟疾和严重疾病的风险最高。由于能够在美国传播疟疾的按蚊（媒介）的耐力，疟疾传播可能在美国恢復的永久风险。根据全球基金 2022 年 4 月的资料，与疟疾相关的病例和死亡人数上升，主要是由于资金停滞和 COVID-19 大流行造成的干扰。然而，正如2022 年9 月全球基金报告中所提到的那样，减轻这些影响的努力已取得进展。由美国全球疟疾委员会监督协调员。根据全球卫生政策，2022 财政年度美国用于疟疾控制和研究活动的资金约为 10 亿美元。长期目标。

因此，美国疟疾治疗市场的成长是由疟疾患者数量的增加所推动的。

北美疟疾治疗市场收入及 2030 年预测（百万美元）

北美疟疾治疗市场细分

北美疟疾治疗市场根据治疗、给药途径、配销通路和国家进行细分。根据治疗方法，北美疟疾治疗市场分为仿製药、原厂药、疫苗等。 2022 年，疫苗领域占据最大的市场。

就给药途径而言，北美疟疾治疗市场分为口服和肠外给药。 2022年，口腔细分市场占据了更大的市场。

依配销通路，北美疟疾治疗市场分为直接招标、医院药局、零售药局、线上药局等。 2022 年，直接招标领域占据最大的市场份额。

依国家/地区划分，北美疟疾治疗市场分为美国、加拿大和墨西哥。 2022年，美国在北美疟疾治疗市场份额中占据主导地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、赛诺菲 SA、GSK Plc、诺华 AG、辉瑞 Inc、AdvaCare Pharma USA LLC、VLP Therapeutics LLC 和 Lupin Ltd 是北美疟疾治疗市场的一些领先参与者。

Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species-Plasmodium falciparum and P. vivax-are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). Thus, the rising prevalence of malaria boosts the malaria treatment market growth.

North America Malaria Treatment Market Overview

According to the Centers for Disease Control and Prevention (CDC), approximately 2,000 cases of malaria are reported annually in the US, mostly in travelers from other countries and immigrants. Pregnant women and children under 5 years of age are at the highest risk of contracting malaria and developing severe diseases. There is a perpetual risk that malaria transmission can resume in the US due to the endurance of anopheles mosquitoes (vectors) capable of transmitting malaria in the US. According to the Global Fund data from April 2022, cases and deaths related to malaria rose mainly due to stalled funding and disruptions caused by the COVID-19 pandemic. However, efforts to moderate these impacts have seen progress, as mentioned in the Global Fund report in September 2022. Efforts taken by the US government to control malaria include activities primarily through the US President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to Global Health Policy, US funding for malaria control and research activities was approximately US$ 1 billion in FY 2022. The US government's goal under the PMI Strategy 2021-2026 is to work and reduce deaths caused by malaria and decrease malaria morbidity, in turn approaching its long-term goal of elimination.

Thus, the malaria treatment market growth in the US is driven by the rising number of malaria patients.

North America Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Malaria Treatment Market Segmentation

The North America malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the North America malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The vaccines segment held the largest market share in 2022.

In terms of route of administration, the North America malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the North America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the North America malaria treatment market is segmented into the US, Canada, and Mexico. The US dominated the North America malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd are some of the leading players operating in the North America malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
- 4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - North America Market Analysis

5.1 North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Malaria Treatment Market - Country Analysis

9.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
- 9.1.1 Overview
  - 9.1.1.1 North America: Malaria Treatment Market, by Country
  - 9.1.1.2 US
  - 9.1.1.3 Overview
    - 9.1.1.3.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 US: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 US: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 US: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 US: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 Canada
  - 9.1.1.5 Overview
    - 9.1.1.5.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 Canada: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 Canada: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 Mexico
  - 9.1.1.7 Overview
    - 9.1.1.7.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 Mexico: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 Mexico: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 VLP Therapeutics LLC
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Lupin Ltd
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 5. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 22. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. North America: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Growth Strategies in the Malaria Treatment Market